Login / Signup

Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study.

Maile T PhillipsMarina AntillonJoke BilckeNaor Bar-ZeevFumbani LimaniFrédéric DebellutClint PecenkaKathleen M NeuzilMelita A GordonDeus ThindwaA David PaltielReza YaesoubiVirginia E Pitzer
Published in: BMC infectious diseases (2023)
Countries for which the spread of antimicrobial resistance is likely to lead to outbreaks of typhoid fever should consider TCV introduction. Reactive vaccination can be a cost-effective strategy, but only if delays in vaccine deployment are minimal; otherwise, introduction of preventive routine immunization with a catch-up campaign is the preferred strategy.
Keyphrases
  • antimicrobial resistance
  • cancer therapy
  • drug delivery
  • infectious diseases